Constrained phytoestrogens and analogues as ERβ selective ligands
摘要:
A new series of ERbeta (ERbeta) selective ligands has been prepared. One of the compounds 6, structurally related to the phytoestrogen apigenin 4, displays a binding preference for ERbeta over ERalpha of over 40-fold. In addition to its binding selectivity, 6 was able to potently induce metallothionein (an ERbeta specific response in human SAOS-2 cells) while demonstrating low potency in an ERalpha dependant ERE-tk luciferase assay in MCF-7 cells. Such receptor and cell selectivity could make 6 a useful molecular probe for better understanding the role of ERbeta in mammalian physiology. (C) 2003 Elsevier Science Ltd. All rights reserved.
Constrained phytoestrogens and analogues as ERβ selective ligands
摘要:
A new series of ERbeta (ERbeta) selective ligands has been prepared. One of the compounds 6, structurally related to the phytoestrogen apigenin 4, displays a binding preference for ERbeta over ERalpha of over 40-fold. In addition to its binding selectivity, 6 was able to potently induce metallothionein (an ERbeta specific response in human SAOS-2 cells) while demonstrating low potency in an ERalpha dependant ERE-tk luciferase assay in MCF-7 cells. Such receptor and cell selectivity could make 6 a useful molecular probe for better understanding the role of ERbeta in mammalian physiology. (C) 2003 Elsevier Science Ltd. All rights reserved.
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
申请人:Wyeth
公开号:US20030087955A1
公开(公告)日:2003-05-08
This invention provides estrogen receptor modulators of formula 1, having the structure
1
wherein
X, Y
1
, Y
2
, Y
3
, Y
4
, Z
1
, Z
2
, Z
3
, and Z
4
are as defined in the specification, or a pharmaceutically acceptable salt thereof.
Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
申请人:Wyeth
公开号:US06589980B2
公开(公告)日:2003-07-08
This invention provides estrogen receptor modulators of formula I, having the structure
wherein
X, Y1, Y2, Y3, Y4, Z1, Z2, Z3, and Z4 are as defined in the specification, or a pharmaceutically acceptable salt thereof.